Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
Toxins|October 4, 2017
Treatments for Pulmonary Ricin Intoxication: Current Aspects and Future ProspectsYoav Gal, Ohad Mazor, Reut Falach, et al.Toxins|February 14, 2018
Novel Phage Display-Derived Anti-Abrin Antibodies Confer Post-Exposure Protection against Abrin IntoxicationAdva Mechaly, Ron Alcalay, Tal Noy-Porat, et al.Photochemistry and Photobiology|April 21, 2005
Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity and the effect of serum proteinsAlexander Brandis, Ohad Mazor, Eran Neumark, et al.Bioconjugate Chemistry|June 30, 2015
Acetylcholinesterase-Fc Fusion Protein (AChE-Fc): A Novel Potential Organophosphate Bioscavenger with Extended Plasma Half-LifeTal Noy-Porat, Ofer Cohen, Sharon Ehrlich, et al.Toxicon : Official Journal of the International Society on Toxinology|January 17, 2017
Extended therapeutic window for post-exposure treatment of ricin intoxication conferred by the use of high-affinity antibodiesTal Noy-Porat, Ron Alcalay, Eyal Epstein, et al.Antibodies (Basel, Switzerland)|February 21, 2025
Purification of a Fc-Fusion Protein with [Bathophenathroline:metal] ComplexesThisara Jayawickrama Withanage, Ron Alcalay, Olga Krichevsky, et al.Antibodies (Basel, Switzerland)|May 1, 2020
Mapping Immunodominant Antibody Epitopes of AbrinRon Alcalay, Reut Falach, Yoav Gal, et al.Journal of Immunological Methods|November 25, 2018
A primer set for comprehensive amplification of V-genes from rhesus macaque origin based on repertoire sequencingRonit Rosenfeld, Anat Zvi, Eitan Winter, et al.Toxicology Letters|June 9, 2015
Antibody treatment against pulmonary exposure to abrin confers significantly higher levels of protection than treatment against ricin intoxicationTamar Sabo, Yoav Gal, Eitan Elhanany, et al.Chemico-Biological Interactions|December 17, 2009
Next generation OP-bioscavengers: a circulatory long-lived 4-PEG hypolysine mutant of F338A-HuAChE with optimal pharmacokinetics and pseudo-catalytic characteristicsChanoch Kronman, Ofer Cohen, Ohad Mazor, et al.Pageof 6